ELITE PHARMACEUTICALS INC /NV/ reports

Company location: Northvale, NJ
Fiscal year end: 31 March

ELITE PHARMACEUTICALS INC /NV/ has filed 1,215 SEC EDGAR filings since 30 Jan 1998

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 401-425 of 753 matching filings.

Per page

25

Current page

17

4

PRIMARY DOCUMENT

Filing date: 31 Mar 2014
Reporting date: 27 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 18 Mar 2014
Reporting date: 19 Jun 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 18 Mar 2014
Reporting date: 12 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

5

PRIMARY DOCUMENT

Filing date: 18 Mar 2014
Reporting date: 31 Mar 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

3/A

PRIMARY DOCUMENT

Filing date: 18 Mar 2014
Reporting date: 18 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

424B3 File 333-188139

424B3

Filing date: 18 Mar 2014
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-15697

8-K

Filing date: 18 Mar 2014
Reporting date: 17 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

PRE 14A File 001-15697

PRE 14A

Filing date: 18 Mar 2014
Reporting date: 17 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Mar 2014
Reporting date: 11 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Mar 2014
Reporting date: 11 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Mar 2014
Reporting date: 11 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Mar 2014
Reporting date: 12 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 10 Mar 2014
Reporting date: 06 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 10 Mar 2014
Reporting date: 06 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 10 Mar 2014
Reporting date: 06 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 10 Mar 2014
Reporting date: 06 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Mar 2014
Reporting date: 25 Feb 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Mar 2014
Reporting date: 25 Feb 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 27 Feb 2014
Reporting date: 25 Feb 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 27 Feb 2014
Reporting date: 25 Feb 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 27 Feb 2014
Reporting date: 25 Feb 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 27 Feb 2014
Reporting date: 07 Feb 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 27 Feb 2014
Reporting date: 25 Feb 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D File 005-59693

SC 13D

Filing date: 19 Feb 2014
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B3 File 333-188139

424B3

Filing date: 18 Feb 2014
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .